Glucagon biosimilar - USV
Latest Information Update: 22 May 2015
At a glance
- Originator USV
- Class Antihypoglycaemics; Pancreatic hormones
- Mechanism of Action Glucagon receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Hypoglycaemia
Most Recent Events
- 22 May 2015 Early research in Hypoglycaemia in India (SC) (USV product pipeline, May 2015)